Codiak BioSciences, Inc. 4 SEC Filings

Filed On	Filing
30 Mar 2023	Form 4: Howze Yalonda, See Remarks Sold 1,628 shares ($318)
30 Mar 2023	Form 4: Sathyanarayanan Sriram, Chief Scientific Officer Sold 11,762 shares ($1.94K)
30 Mar 2023	Form 4: Konstantinov Konstantin, Chief Technology Officer Sold 9,364 shares ($1.87K)
30 Mar 2023	Form 4: Bain Linda, Chief Financial Officer Sold 13,412 shares ($2.27K)
30 Mar 2023	Form 4: Barna Nicole, See Remarks Sold 7,305 shares ($1.21K)
30 Mar 2023	Form 4: Williams Douglas E, Director Sold 41,667 shares ($7.5K)
21 Feb 2023	Form 4: Bain Linda, Chief Financial Officer Received 7,613 shares by exercise or conversion · Sold 2,364 shares ($5.23K) · Received 7,613 shares by exercise or conversion · 1 more
21 Feb 2023	Form 4: Williams Douglas E, Director Received 22,969 shares by exercise or conversion · Sold 7,112 shares ($15.7K) · Received 22,969 shares by exercise or conversion · 1 more
21 Feb 2023	Form 4: Konstantinov Konstantin, Chief Technology Officer Received 4,200 shares by exercise or conversion · Sold 1,308 shares ($2.89K) · Received 4,200 shares by exercise or conversion · 1 more
21 Feb 2023	Form 4: Bernstein Karen, Director Received 8,750 shares by exercise or conversion
21 Feb 2023	Form 4: Haddock Jason, Director Received 8,750 shares by exercise or conversion
21 Feb 2023	Form 4: Sathyanarayanan Sriram, Chief Scientific Officer Received 7,350 shares by exercise or conversion · Sold 2,283 shares ($5.05K) · Received 7,350 shares by exercise or conversion · 1 more
21 Feb 2023	Form 4: Gillis Steven, Director Received 8,750 shares by exercise or conversion
21 Feb 2023	Form 4: Cooney Charles L, Director Received 8,750 shares by exercise or conversion
21 Feb 2023	Form 4: Barna Nicole, See Remarks Received 3,150 shares by exercise or conversion · Sold 984 shares ($2.18K) · Received 3,150 shares by exercise or conversion · 1 more
21 Feb 2023	Form 4: Howze Yalonda, See Remarks Received 4,857 shares by exercise or conversion · Sold 1,512 shares ($3.35K) · Received 4,856 shares by exercise or conversion · 1 more
21 Feb 2023	Form 4: Melas Kyriazi Theo, Director Received 8,750 shares by exercise or conversion
26 Jan 2023	Form 4: Konstantinov Konstantin, Chief Technology Officer Granted 145,000 Stock Option (Right to Buy)
26 Jan 2023	Form 4: Mauro David J, Chief Medical Officer Granted 190,000 Stock Option (Right to Buy)
26 Jan 2023	Form 4: Bain Linda, Chief Financial Officer Granted 185,000 Stock Option (Right to Buy)

Comments